HK1045262B - Gardos通道拮抗劑 - Google Patents

Gardos通道拮抗劑 Download PDF

Info

Publication number
HK1045262B
HK1045262B HK02106773.8A HK02106773A HK1045262B HK 1045262 B HK1045262 B HK 1045262B HK 02106773 A HK02106773 A HK 02106773A HK 1045262 B HK1045262 B HK 1045262B
Authority
HK
Hong Kong
Prior art keywords
compound
substituent
compounds
ring
acetamide
Prior art date
Application number
HK02106773.8A
Other languages
English (en)
Chinese (zh)
Other versions
HK1045262A1 (en
Inventor
G‧A‧麦克诺顿-史密斯
G‧A‧麥克諾頓-史密斯
G‧C‧里格登
J‧W‧施特克尔
J‧W‧施特克爾
Original Assignee
安克进药物公司
安克進藥物公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 安克进药物公司, 安克進藥物公司 filed Critical 安克进药物公司
Publication of HK1045262A1 publication Critical patent/HK1045262A1/xx
Publication of HK1045262B publication Critical patent/HK1045262B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/65—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/11—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK02106773.8A 1999-02-23 2000-02-10 Gardos通道拮抗劑 HK1045262B (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US13551199P 1999-02-23 1999-02-23
US09/386,601 US6288122B1 (en) 1999-02-23 1999-08-31 Gardos channel antagonists
US09/386,601 1999-08-31
PCT/US2000/003663 WO2000050026A1 (en) 1999-02-23 2000-02-10 Gardos channel antagonists

Publications (2)

Publication Number Publication Date
HK1045262A1 HK1045262A1 (en) 2002-11-22
HK1045262B true HK1045262B (zh) 2005-07-29

Family

ID=26833406

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02106773.8A HK1045262B (zh) 1999-02-23 2000-02-10 Gardos通道拮抗劑

Country Status (16)

Country Link
US (1) US6288122B1 (https=)
EP (1) EP1158971B1 (https=)
JP (2) JP4038337B2 (https=)
KR (1) KR100705726B1 (https=)
CN (1) CN1193748C (https=)
AP (1) AP1465A (https=)
AT (1) ATE370728T1 (https=)
AU (1) AU762039B2 (https=)
BR (1) BR0008416A (https=)
CA (1) CA2371857C (https=)
DE (1) DE60036093T2 (https=)
ES (1) ES2291191T3 (https=)
HK (1) HK1045262B (https=)
IL (2) IL145012A0 (https=)
OA (1) OA11838A (https=)
WO (1) WO2000050026A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003004010A1 (en) * 2001-07-06 2003-01-16 Poseidon Pharmaceuticals A/S Carbonylamino derivatives useful for obtaining immune regulation
JP4394451B2 (ja) * 2002-01-04 2010-01-06 ニューロサーチ、アクティーゼルスカブ カリウムチャネルモジュレーター
US20040029771A1 (en) * 2002-02-28 2004-02-12 Icagen, Inc. Methods for treating diseases related to intraocular pressure
WO2005003143A1 (en) * 2003-07-03 2005-01-13 Poseidon Pharmaceuticals A/S Novel potassium channel modulators
WO2005003094A1 (en) * 2003-07-03 2005-01-13 Poseidon Pharmaceuticals A/S Diarylmethyl derivatives as potassium channel modulators
US7709533B2 (en) * 2005-02-01 2010-05-04 Icagen, Inc. Imines as ion channel modulators
KR20080086511A (ko) * 2005-12-20 2008-09-25 이카겐, 인코포레이티드 트리아릴 메탄 화합물을 이용한 치료 방법
US20100056637A1 (en) * 2005-12-20 2010-03-04 Icagen, Inc. Treatment methods using triaryl methane compounds
ES2358564T3 (es) 2007-08-24 2011-05-11 Neurosearch A/S Derivados de carbonilamino útiles para el tratamiento de una enfermedad inflamatoria intestinal.
US20090076157A1 (en) * 2007-09-15 2009-03-19 Protia, Llc Deuterium-enriched senicapoc
CA2720824C (en) 2008-04-09 2021-09-14 Cerus Corporation Improved quenching methods for red blood cell pathogen inactivation
CN102272152B (zh) 2008-11-10 2014-05-28 贝林格尔.英格海姆国际有限公司 通过中电导钙激活钾通道调控细胞-细胞融合的组合物及方法
WO2016134353A1 (en) * 2015-02-20 2016-08-25 Children's Medical Center Corporation Methods for treating malaria using potassium channel inhibitors
EP3106155A1 (en) * 2015-06-15 2016-12-21 Universite d'Aix Marseille Treatment and diagnosis of hereditary xerocytosis
WO2018081018A1 (en) * 2016-10-25 2018-05-03 Paracelsus Neuroscience Llc Use of senicapoc for treatment of neuropathic pain
WO2018162426A1 (en) 2017-03-06 2018-09-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Treatment and diagnosis of hereditary xerocytosis
CN112020353A (zh) * 2019-03-29 2020-12-01 深圳仁泰医药科技有限公司 2,2-双(4-氟苯基)-2-苯乙酰胺的晶型a及其制备方法和应用
US12186286B2 (en) * 2019-07-29 2025-01-07 Paracelsus Neuroscience Llc Use of senicapoc for treatment of stroke
WO2022015893A2 (en) * 2020-07-14 2022-01-20 Adimabio Llc Compositions comprising gardos channel antagonists and their uses
EP4259130B1 (en) * 2020-12-11 2026-03-04 Sanquin IP B.V. Gardos channel inhibitor or other agents for use in the treatment and prevention of anaemia of inflammation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5273992A (en) 1992-11-02 1993-12-28 Beth Israel Hospital Assoc. Inc. Method for reducing sickle erythrocyte dehydration and delaying the occurrence of erythrocyte sickling in-situ
AU732881C (en) 1994-09-16 2002-11-07 Children's Medical Center Corporation Triaryl and diaryl compounds, their analogues and uses thereof

Also Published As

Publication number Publication date
AU2880700A (en) 2000-09-14
JP2007262075A (ja) 2007-10-11
ATE370728T1 (de) 2007-09-15
CN1193748C (zh) 2005-03-23
HK1045262A1 (en) 2002-11-22
JP2002537331A (ja) 2002-11-05
WO2000050026A1 (en) 2000-08-31
CA2371857A1 (en) 2000-08-31
CN1344158A (zh) 2002-04-10
JP4038337B2 (ja) 2008-01-23
KR100705726B1 (ko) 2007-04-11
EP1158971A1 (en) 2001-12-05
EP1158971A4 (en) 2003-04-16
OA11838A (en) 2005-08-22
ES2291191T3 (es) 2008-03-01
DE60036093D1 (de) 2007-10-04
US6288122B1 (en) 2001-09-11
IL145012A (en) 2006-12-10
CA2371857C (en) 2008-07-29
AP1465A (en) 2005-09-22
IL145012A0 (en) 2002-06-30
AU762039B2 (en) 2003-06-19
AP2001002268A0 (en) 2001-09-30
BR0008416A (pt) 2002-01-29
DE60036093T2 (de) 2008-05-15
KR20020002393A (ko) 2002-01-09
EP1158971B1 (en) 2007-08-22

Similar Documents

Publication Publication Date Title
CN1193748C (zh) Gardos通道拮抗剂
CN85107020A (zh) 烷基亚磺酰胺基苯基烷基胺的制备方法
CN1012433B (zh) 白三烯拮抗剂的制备方法
CN1255136A (zh) 取代的4－芳基亚甲基－2－亚氨基－2,3－二氢噻唑和衍生物及其药学应用
CN1261877A (zh) 4－溴或4－碘苯基氨基苯氧肟酸衍生物及其作为mek抑制剂的用途
CN1791576A (zh) 代谢型谷氨酸受体的苯甲酰胺调节剂
CN1589264A (zh) 用于治疗恶性肿瘤的方法
CN1805921A (zh) 选择性雄激素受体调节剂的前药及其使用方法
CN1023402C (zh) 制备5-羟色胺拮抗药的方法
CN1079789C (zh) 新的羟肟酸衍生物,包含它们的药物组合物及其制法
CN1126990A (zh) 新的(1-苯基-1-杂环基)烷烃衍生物和作为神经保护剂的应用
CN1014515B (zh) 制备mao抑制剂—非芳香族氟烯丙胺的方法
CN1960974A (zh) 烷基取代的哌啶衍生物及其作为单胺神经递质再摄取抑制剂的用途
CN1015175B (zh) 苯甲酰胺类抗惊厥剂的制备方法
CN1177852C (zh) 膦酸二酯衍生物
CN1914169A (zh) 作为环氧合酶－2抑制剂的二芳基－2－(5h)－呋喃酮的氧化氮释放前药
CN88103114A (zh) 杂环化合物
CN1466573A (zh) 5-苯基苄胺化合物、其制备方法以及其合成中间体
CN1249018C (zh) 用于镰状细胞疾病的三芳基甲烷化合物
CN1232388A (zh) 抗疟疾和抗巴贝虫病剂和含有它们的药物组合物
CN1306422A (zh) 用于治疗或预防以异常细胞增殖为特征之疾病的经取代的二苯基茚满酮、茚满和吲哚化合物及其类似物
CN1034710A (zh) 新化合物
CN1170716A (zh) 双－邻位取代的苯甲酰胍、其制备方法、用途及含有它们的药物
CN88103112A (zh) 酰胺类化合物
CN1264383A (zh) 光学活性亚砜衍生物的盐

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140210